Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 256, doi. 10.18502/cjn.v21i4.11724
- By:
- Publication type:
- Article
Works matching IS 2717011X AND DT 2022 AND VI 21 AND IP 4
Results: 10
1
2
Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
3
Transient global amnesia after COVID-19: A systematic scoping review of case reports.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 244, doi. 10.18502/cjn.v21i4.11722
- By:
- Publication type:
- Article
4
Association between plasma PCSK9 levels and lipid profile in patients with Parkinson's disease and comparison with healthy subjects.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 236, doi. 10.18502/cjn.v21i4.11721
- By:
- Publication type:
- Article
5
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 230, doi. 10.18502/cjn.v21i4.11720
- By:
- Publication type:
- Article
6
The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 224, doi. 10.18502/cjn.v21i4.11719
- By:
- Publication type:
- Article
7
Trend of incidence and mortality of brain and central nervous system cancer in Iran from 1990 to 2017: A global burden of disease-based study.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 217, doi. 10.18502/cjn.v21i4.11718
- By:
- Publication type:
- Article
8
The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 211, doi. 10.18502/cjn.v21i4.11717
- By:
- Publication type:
- Article
9
Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorder.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 206, doi. 10.18502/cjn.v21i4.11716
- By:
- Publication type:
- Article
10
Adding erythropoietin to intravenous methylprednisolone in acute treatment of attacks of neuromyelitis optica spectrum disorders: A randomized controlled trial.
- Published in:
- Current Journal of Neurology, 2022, v. 21, n. 4, p. 201, doi. 10.18502/cjn.v21i4.11715
- By:
- Publication type:
- Article